201003 March 2010 | Market Landscape and Best Practices for Biopharmaceutical Players in China
“What’s your China strategy?” is a query heard in most sectors of the economy, and biotech is no exception. This paper looks into the strategies biopharmaceutical firms should take in approaching the China market, focusing particular attention on the role of government regulation and intellectual property protection. Specific strategies examined by the research include filing patent applications in China, using Chinese contract research organizations to achieve cost savings in research and development, conducting portions of clinical trials in China, and licensing products to firms with an established domestic sales force.
|
200704 April 2007 | Battling HIV/AIDS in Brazil
The number of people living with HIV/AIDS in the world today has risen to 33.2 million, with some 2.5 million people newly infected in 2007.1 The disease is one of the leading causes of death worldwide, particularly in developing countries. But Brazil is one developing country that has committed to fighting back. Through comprehensive and effective public policy, the Brazilian government has made significant strides in combating the epidemic and has earned a place at the forefront of HIV/AIDS prevention and treatment. |
200704 April 2007 | A Prescription to Kill
Chinese and multinational drug manufacturers alike are enjoying the benefits of population growth, with double-digit increases in annual revenues. But there is a dark side: China is already the world’s largest producer of counterfeit drugs, with such products—including ingredients benign as baking soda or harmful as rat poison—accounting for 63% of the country’s pharmaceutical market. Counterfeit drug-making is a problem escalating on multiple fronts: from developing countries like Africa to the most developed, including the United States, where an estimated 5 to7 percent of drugs sold have been tampered with. |
200704 April 2007 | Detecting Infant HIV/AIDS in Sub-Saharan Africa
Public health experts agree that early diagnosis of children at risk for contracting HIV/AIDS from HIV-positive mothers in sub-Saharan Africa is vital to reducing the disease’s terrible toll; early detection can help prevent transmission during birth or breastfeeding and improve the outcome for children carrying the virus. |